IPO registrations (S-1, F-1) · Registrants

Artemis Strategic Investment Corp

SEC CIK
1839990 · filings on EDGAR ↗
Registration
Form S-1, first filed 2021-02-12, last 2021-09-21; 1 initial registration, 6 amendments
Outcome
Final prospectus filed 2021-10-01; declared effective 2021-09-29
Industry (SIC)
Wholesale-Drugs, Proprietaries & Druggists' Sundries 5122
Business address
3310 EAST CORONA AVENUE, Phoenix, AZ 85040
EDGAR entity type
operating
Insiders and CEO pay
Artemis Strategic Investment Corp on the corporate pages

Offering terms

Final price
$10.00 per share (424B4 filed 2021-10-01, an initial public offering)
Shares sold
17,500,000
Gross proceeds
$175,000,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol ARTE
Lead underwriters
Barclays; BMO Capital Markets

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 9

FiledFormWhat it isName as filedEDGAR
2021-02-12S-1S-1 (registration)Artemis Strategic Investment Corp0001104659-21-022127 ↗
2021-03-03S-1/AS-1/A (amendment)Artemis Strategic Investment Corp0001104659-21-030983 ↗
2021-03-19S-1/AS-1/A (amendment)Artemis Strategic Investment Corp0001104659-21-039154 ↗
2021-03-26S-1/AS-1/A (amendment)Artemis Strategic Investment Corp0001104659-21-042310 ↗
2021-06-09S-1/AS-1/A (amendment)Artemis Strategic Investment Corp0001104659-21-078403 ↗
2021-08-31S-1/AS-1/A (amendment)Artemis Strategic Investment Corp0001104659-21-111397 ↗
2021-09-21S-1/AS-1/A (amendment)Artemis Strategic Investment Corp0001104659-21-117496 ↗
2021-09-29EFFECTEFFECT (declared effective)Artemis Strategic Investment Corp9999999995-21-003687 ↗
2021-10-01424B4424B4 (final prospectus)Artemis Strategic Investment Corp0001104659-21-122043 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2021-09-21S-1/Aregistration statement$10.0017,500,000$175,000,000Nasdaq ARTE2primary document; price sentence, shares headline, proceeds table, cover names 2document ↗
2021-10-01424B4final prospectus$10.0017,500,000$175,000,000Nasdaq ARTE2primary document; price sentence, shares headline, proceeds table, cover names 2document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
Anfinson MatthewDirector12021
Artemis Sponsor LLCTenPercentOwner22021
Butler RodneyDirector12021
Gagnon HollyDirector,Officer,TenPercentOwnerCo-CEO and Chairperson12021
Granite ThomasOfficerCFO, Treasurer and Secretary12021
KAPLAN PHILIP NOfficer,TenPercentOwnerCo-CEO and President12021
Massion AnnaDirector12021
Nodarse-Leon AndroDirector12021
Shulak ScottOfficerSVP, Acquisitions & Accounting12021
WANGER LEONARDDirector12021
Atlas Merchant Capital LLCTenPercentOwner12023

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
SEC filerArtemis Strategic Investment CorpSEC filers (EDGAR)CIK (EXACT)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Wholesale-Drugs, Proprietaries & Druggists' Sundries, AZ first:

More with this interest.

Interests: Wholesale-Drugs, Proprietaries & Druggists' Sundries